← Back to Search

DT1 Sphere Contact Lenses for Dry Eye Syndrome

N/A
Waitlist Available
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month
Awards & highlights

Study Summary

This trial found that out of 48 participants, 25 (52.1%) were successful in refitting with DT1.

Eligible Conditions
  • Dry Eye Syndrome
  • Contact Lens Complication

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Visual Analog Scale (VAS) Contact Lenses Comfort Scores

Trial Design

1Treatment groups
Experimental Treatment
Group I: Dailies Total1Experimental Treatment1 Intervention
All participants will be asked to wear Dailies Total1 for the duration of this study.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
DT1 Sphere Contact Lenses
2022
N/A
~60

Find a Location

Who is running the clinical trial?

Alcon ResearchIndustry Sponsor
703 Previous Clinical Trials
124,411 Total Patients Enrolled
University of Alabama at BirminghamLead Sponsor
1,583 Previous Clinical Trials
2,279,984 Total Patients Enrolled

Media Library

DT1 Sphere Contact Lenses Clinical Trial Eligibility Overview. Trial Name: NCT05239494 — N/A
Dry Eye Syndrome Research Study Groups: Dailies Total1
Dry Eye Syndrome Clinical Trial 2023: DT1 Sphere Contact Lenses Highlights & Side Effects. Trial Name: NCT05239494 — N/A
DT1 Sphere Contact Lenses 2023 Treatment Timeline for Medical Study. Trial Name: NCT05239494 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there currently available vacancies for individuals wishing to participate in this trial?

"Affirmative. Clinicaltrials.gov displays the information that this medical trial, which was first published on May 23rd 2022, is actively recruiting participants. Specifically, they are looking to enroll 60 patients from 4 different sites."

Answered by AI

How many health care facilities are conducting this research endeavor?

"Currently, 4 clinical sites are enrolling patients in this trial. Participants can find medical centres Birmingham, Pittsburg and Memphis as well as other nearby locations. For the sake of convenience, it is suggested to join a site closest to one's residence if they choose to partake in the study."

Answered by AI

How many individuals have registered to participate in this research?

"In order to conduct the trial, Alcon Research needs 60 qualified participants. The sponsor will be running this study out of two separate medical centres: University of Alabama at Birmingham in Birmingham, Alabama and Kannarr Eye Care in Pittsburg, Kansas."

Answered by AI

Does the recruitment criteria for this experiment extend to those aged 45 and above?

"The acceptable age range for this clinical trial is 18-40. For younger or older patients, there are 3 trials and 82 trials respectively that may be suitable options."

Answered by AI

To what demographics is enrollment in this study open?

"This clinical trial is seeking 60 individuals aged 18 to 40 that have experienced difficulties while wearing contact lenses. Prospective participants must possess 20/20 vision or better, had worn contact lenses for at least one year prior, ceased wearing the lenses within two years due to discomfort or dryness, and scored 3 points of lower on the SPEED questionnaire. Furthermore, an updated glasses prescription less than three-years-old is required in order to be refitted with Dailies Total1 Sphere contact lens."

Answered by AI
~21 spots leftby Apr 2025